Search Results
-
Common conditions driving birth inequity
Untreated high blood pressure and anemia in pregnancy help explain why childbirth complications are more common in non-white populations, two studies led by Stanford Medicine researchers found.
-
Memory in general hindered in autism
Memory impairment in autism goes beyond poor facial recognition, a Stanford Medicine team showed. The finding suggests a wide role for memory in the neurobiology of the disorder.
-
Reversing a cystic fibrosis complication before birth
Giving a new cystic fibrosis medication to a pregnant woman who carries the gene for the disease was unexpectedly beneficial for her fetus, a Stanford Medicine team found.
-
DNA circles drive cancer development
Tiny circles of DNA harbor cancer-associated oncogenes and immunomodulatory genes promoting cancer development. They arise during transformation from pre-cancer to cancer, say Stanford Medicine-led team.
-
Predicting prematurity complications
Stanford Medicine scientists and their colleagues have shown they can tap mothers’ and babies’ medical records to better predict newborn health risks.
-
$18 million for transplant and gene-editing research
The California Institute for Regenerative Medicine has funded Stanford Medicine projects to improve kidney transplantation and advance treatment for a rare genetic disease in children.
-
Autism hinders grasp of vocal emotion
Children with autism have trouble identifying emotional tones because of differences in a brain region that processes social information, a Stanford Medicine study found.
-
How COVID-19 virus infects nasal cells
A discovery by Stanford Medicine researchers and colleagues may pave the way for a “morning after” or prophylactic nasal spray to prevent infection.
-
Blood test identifies infections
A diagnostic test developed by Stanford Medicine scientists can separate bacterial and viral infections with 90% accuracy, the first to meet standards set by the World Health Organization.
-
Gel treatment heals blistering wounds
Researchers find that a gel tested in patients with a life-threatening blistering skin disease helps wounds heal. The gel — the first topical gene therapy — awaits FDA approval.